The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
Open accessAbstract
Cancer-associated fibroblasts (CAF) are a major constituent of the tumor stroma, but little is known about how cancer cells transform normal fibroblasts into CAFs. microRNAs (miRNA) are small noncoding RNA molecules that negatively regulate gene expression at a posttranscriptional level. Although it is clearly established that miRNAs are deregulated in human cancers, it is not known whether miRNA expression in resident fibroblasts is affected by their interaction with cancer cells. We found that in ovarian CAFs, miR-31 and miR-214 were downregulated, whereas miR-155 was upregulated when compared with normal or tumor-adjacent fibroblasts. Mimicking this deregulation by transfecting miRNAs and miRNA inhibitors induced a functional conversion of normal fibroblasts into CAFs, and the reverse experiment resulted in the reversion of CAFs into normal fibroblasts. The miRNA-reprogrammed normal fibroblasts and patient-derived CAFs shared a large number of upregulated genes highly enriched in chemokines, which are known to be important for CAF function. The most highly upregulated chemokine, CCL5, (C-C motif ligand 5) was found to be a direct target of miR-214. These results indicate that ovarian cancer cells reprogram fibroblasts to become CAFs through the action of miRNAs. Targeting these miRNAs in stromal cells could have therapeutic benefit. Significance: The mechanism by which quiescent fibroblasts are converted into CAFs is unclear. The present study identifies a set of 3 miRNAs that reprogram normal fibroblasts to CAFs. These miRNAs may represent novel therapeutic targets in the tumor microenvironment. Cancer Discov; 2(12); 1100–8. ©2012 AACR. Read the Commentary on this article by Chou and Werb, p. 1078 This article is highlighted in the In This Issue feature, p. 1065
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Non-coding RNAs and cancer: microRNAs and beyond
Raia, R. M., & Calin, G. A. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.e5 · Cited by 3,382
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
Self-citationOvarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
Self-citationErez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
Schickel, R., Boyerinas, B., Park, S.-M., & Peter, M. E. (2008) · Oncogene · doi:10.1038/onc.2008.274 · Cited by 719
Self-citationDistinct epigenetic changes in the stromal cells of breast cancers
Hu, M., Yao, J., Cai, L., Bachman, K. E., van den Brûle, F., Velculescu, V., & Polyak, K. (2005) · Nature Genetics · doi:10.1038/ng1596 · Cited by 520
Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions
Ambasudhan, R., Talantova, M., Coleman, R., Yuan, X., Zhu, S., Lipton, S. A., & Ding, S. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.07.002 · Cited by 481
Let-7 expression defines two differentiation stages of cancer
Shell, S., Park, S.-M., Radjabi, A. R., Schickel, R., Kistner, E. O., Jewell, D. A., Feig, C., Lengyel, E., & Peter, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704372104 · Cited by 458
Self-citationExtracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
Barkan, D., Green, J. E., & Chambers, A. F. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.027 · Cited by 377
Kenny, H. A., Kaur, S., Coussens, L. M., & Lengyel, E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33775 · Cited by 370
Self-citationHaniffa, M. A., Wang, X.-N., Holtick, U., Rae, M., Isaacs, J. D., Dickinson, A. M., Hilkens, C. M. U., & Collin, M. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1595 · Cited by 346
Breast-Cancer Stromal Cells with TP53 Mutations and Nodal Metastases
Patocs, A., Zhang, L., Xu, Y., Weber, F., Caldes, T., Mutter, G. L., Platzer, P., & Eng, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071825 · Cited by 297
Qiu, W., Hu, M., Sridhar, A., Opeskin, K., Fox, S., Shipitsin, M., Trivett, M., Thompson, E. R., Ramakrishna, M., Gorringe, K. L., et al. (2008) · Nature Genetics · doi:10.1038/ng.117 · Cited by 282
Kenny, H. A., Krausz, T., Yamada, S. D., & Lengyel, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22874 · Cited by 243
Bowen, N. J., Walker, L. D., Matyunina, L. V., Logani, S., Totten, K. A., Benigno, B. B., & McDonald, J. F. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-71 · Cited by 238
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer
Musumeci, M., Coppola, V, Addario, A., Patrizii, M., Maugeri-Saccà, M., Memeo, L., Colarossi, C., Francescangeli, F., Biffoni, M., Collura, D., et al. (2011) · Oncogene · doi:10.1038/onc.2011.140 · Cited by 236
A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3
Sabroe, I., Peck, M. J., Van Keulen, B. J., Jorritsma, A., Simmons, G., Clapham, P. R., Williams, T. J., & Pease, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908864199 · Cited by 219
miR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages
Squadrito, M. L., Pucci, F., Magri, L., Moi, D., Gilfillan, G. D., Ranghetti, A., Casazza, A., Mazzone, M., Lyle, R., Naldini, L., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2011.12.005 · Cited by 206
Naif, H. M., Li, S., Alali, M., Sloane, A., Wu, L., Kelly, M., Lynch, G., Lloyd, A., & Cunningham, A. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.830-836.1998 · Cited by 203
Jørgensen, S., Baker, A., Møller, S., & Nielsen, B. S. (2010) · Methods · doi:10.1016/j.ymeth.2010.07.002 · Cited by 189
Schauer, I. G., Sood, A. K., Mok, S. C., & Liu, J. (2011) · Neoplasia · doi:10.1593/neo.101720 · Cited by 186
Martinez‐Outschoorn, U., Whitaker‐Menezes, D., Pavlides, S., Chiavarina, B., Bonuccelli, G., Trimmer, C., Tsirigos, A., Migneco, G., Witkiewicz, A. K., Balliet, R. M., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13817 · Cited by 173
The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts
Aprelikova, O. N., Xiang, Y., Palla, J. B., Wei, B., John, S., Yi, M., Stephens, R. M., Simpson, R. J., Risinger, J. I., Jazaeri, A. A., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13674 · Cited by 152
Reconstruction of human mammary tissues in a mouse model
Proia, D. A., & Kuperwasser, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.31 · Cited by 144
Kaur, S., Kenny, H. A., Jagadeeswaran, S., Zillhardt, M., MONTAG, A. G., Kistner, E. O., Yamada, S. D., Mitra, A. K., & Lengyel, E. R. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090028 · Cited by 72
Self-citationTsukishiro, S., Suzumori, N., Nishikawa, H., Arakawa, A., & Suzumori, K. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.01.029 · Cited by 59
Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas
Tuhkanen, H. E., Anttila, M., Kosma, V., Heinonen, S. T., Juhola, M. T., Helisalmi, S., Kataja, V. V., & Mannermaa, A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21785 · Cited by 36
Cited by
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Diversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265
Targeting TGF-β signal transduction for fibrosis and cancer therapy
Peng, D., Fu, M., Wang, M., Wei, Y., & Wei, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01569-x · Cited by 1,065
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
Svoronos, A. A., Engelman, D. M., & Slack, F. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0359 · Cited by 791
Metadata
- Authors
- Mitra, A. K., Zillhardt, M., Hua, Y., Tiwari, P., Murmann, A. E., Peter, M. E., & Lengyel, E.
- Venue
- Cancer Discovery
- Published
- 2012-12-01
- Volume
- 2
- Issue
- 12
- Pages
- 1100-1108
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2103560672
- Cited by
- 371
- References
- 31
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.